| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2010 | EP2173717A2 Novel glucokinase activators and methods of using same |
| 04/14/2010 | EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 04/14/2010 | EP2173714A1 Piperidine derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173712A2 Indane-amine derivatives, their preparation and use as medicaments |
| 04/14/2010 | EP2173711A1 Phenoxy-pyrrolidine derivative and its use and compositions |
| 04/14/2010 | EP2173710A1 Novel crystalline form |
| 04/14/2010 | EP2173707A1 Pleuromutilin derivatives and their use as antimicrobials |
| 04/14/2010 | EP2173555A2 Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols |
| 04/14/2010 | EP2173368A1 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 04/14/2010 | EP2173364A1 Treating or preventing rotavirus infection |
| 04/14/2010 | EP2173362A2 Compositions and methods for inhibiting viral and bacterial activity |
| 04/14/2010 | EP2173360A2 Heparosan-based biomaterials and coatings and methods of production and use thereof |
| 04/14/2010 | EP2173359A2 Heparin conjugates and methods |
| 04/14/2010 | EP2173358A1 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 04/14/2010 | EP2173357A2 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 04/14/2010 | EP2173356A1 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals |
| 04/14/2010 | EP2173355A2 Pirenzepine and derivatives thereof as anti-amyloid agents |
| 04/14/2010 | EP2173354A1 Quinoxaline derivatives as pi3 kinase inhibitors |
| 04/14/2010 | EP2173352A2 Inhibitors of akt/pkb with anti-tumor activity |
| 04/14/2010 | EP2173351A2 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 04/14/2010 | EP2173350A2 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 04/14/2010 | EP2173346A2 Use of compounds for preparing anti-tuberculosis agents |
| 04/14/2010 | EP2173345A2 A method for decreasing symptoms of alcohol consumption |
| 04/14/2010 | EP2173344A1 Treatment or prophylaxis or neurological or neuropsychiatric disorders via ocular administration |
| 04/14/2010 | EP2173342A2 Antivirals |
| 04/14/2010 | EP2173340A1 Methods of enhancing cognitive function using non-peptidic compounds |
| 04/14/2010 | EP2173339A1 Campsiandra angustifolia extract and methods of extracting and using such extract |
| 04/14/2010 | EP2173337A2 Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin |
| 04/14/2010 | EP2173336A1 New use of known pharmacologically active chemical compounds |
| 04/14/2010 | EP2173335A2 Beta adrenergic receptor ligand derivatives for modulating apoptosis |
| 04/14/2010 | EP2173334A1 A method of treating amblyopia |
| 04/14/2010 | EP2173329A1 Tolterodine bead |
| 04/14/2010 | EP2173328A1 Solid valsartan composition |
| 04/14/2010 | EP2173326A2 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 04/14/2010 | EP2173323A2 Stimulating gel |
| 04/14/2010 | EP2173316A2 Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants |
| 04/14/2010 | EP2173198A2 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants |
| 04/14/2010 | EP2173174A1 Farnesoid x receptor agonists |
| 04/14/2010 | EP2173173A2 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 04/14/2010 | EP2173172A1 Orally disintegrating tablet compositions of lamotrigine |
| 04/14/2010 | EP2173171A2 Flea control method |
| 04/14/2010 | EP2173170A2 Fused heterocycles |
| 04/14/2010 | EP2173167A2 Treatment of neuropathic pain |
| 04/14/2010 | EP2173166A1 Inhibitors of polysialic acid de-n-acetylase and methods for using the same |
| 04/14/2010 | EP1919869B1 Indole derivatives as ppar activators |
| 04/14/2010 | EP1858890B1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 04/14/2010 | EP1848441B1 Pharmaceutical composition comprising drospirenone and ethynylestradiol |
| 04/14/2010 | EP1809273B1 Use of 2-phenyl-1,2-ethanediol-(di)carbamates for treating epileptogenesis |
| 04/14/2010 | EP1805170B1 Mif-inhibitors |
| 04/14/2010 | EP1799228B1 Topical compositions containing phosphorylated polyphenols |
| 04/14/2010 | EP1796678B1 Carboxamide spirolactam cgrp receptor antagonists |
| 04/14/2010 | EP1786439B1 Methods of activating nkt cells |
| 04/14/2010 | EP1704146B1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1663229B1 Pharmaceutical combinations of hydrocodone and naltrexone |
| 04/14/2010 | EP1656141B1 Treatment for alzheimer s disease and related conditions |
| 04/14/2010 | EP1641745B1 Propionamide derivatives useful as androgen receptor modulators |
| 04/14/2010 | EP1641473B1 Buffered compositions for dialysis |
| 04/14/2010 | EP1627871B1 Cyclic aminophenyl sulfamate derivative |
| 04/14/2010 | EP1599201B1 Selective non-steroidal glucocorticoid receptor modulators |
| 04/14/2010 | EP1586315B1 Skin lightening composition |
| 04/14/2010 | EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/14/2010 | EP1537078B1 Indoles having anti-diabetic activity |
| 04/14/2010 | EP1507533B1 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP1363636B1 A combination comprising levosimendan and a calcium source for the treatment of heart failure |
| 04/14/2010 | EP1347773B1 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/14/2010 | EP1294922B1 Treating cancer using organelle crystallizing agents |
| 04/14/2010 | EP0961833B1 Human plasma hyaluronidase |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1995036B Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative |
| 04/14/2010 | CN1994277B Solid preparation of salvianolic acid A of red sage root and preparation process thereof |
| 04/14/2010 | CN1990500B Application of siatic centella triterpenoid saponin for preparing medicine for treating hepatic fibrosis |
| 04/14/2010 | CN1974594B Human myocardial troponin I subunit nucleic acid adaptor and its application |
| 04/14/2010 | CN1968694B An analgesic pharmaceutical composition |
| 04/14/2010 | CN1953749B Application of 1-(substituted phenyl)-5-methyl-2-(1H)-pyridone (I) compound in preparing medicine for anti-organifibrosis or tissue fibrosis |
| 04/14/2010 | CN1939325B Medicinal composition of houttuynin sodium and astragalin, its making method and usage |
| 04/14/2010 | CN1931218B Medicine composition of ligustrazine and rhodiola root |
| 04/14/2010 | CN1911211B Solid oral preparation of leishajilan |
| 04/14/2010 | CN1891300B Benzocaine film-formed gel composition and its use |
| 04/14/2010 | CN1887317B Externally applied liniment for treating rheumatic and rheumatoid arthritis and its preparation |
| 04/14/2010 | CN1883562B Effervescence tablet for treating climacteric syndrome and method for preparing same |
| 04/14/2010 | CN1864674B Medical use of compound hyrtiosal |
| 04/14/2010 | CN1852690B Medicament conveying system |
| 04/14/2010 | CN1823796B Preparation method of Hainan mountaineous bitter tea lignin and tannin |
| 04/14/2010 | CN1778296B Long-acting preparation for tatin medicine |
| 04/14/2010 | CN1777445B Agent for repairing corneal perception |
| 04/14/2010 | CN1745747B Use of proanthocyanidin in preparing medicine for treating colitis |
| 04/14/2010 | CN1739655B Quality control method of Qingkailing injection preparation |
| 04/14/2010 | CN1736388B Compositions having anti-dental caries function |
| 04/14/2010 | CN1698595B Tiopronin injection and preparation method thereof |
| 04/14/2010 | CN1690067B Antiviral agent cyclo-cidofovir derivatives |
| 04/14/2010 | CN1607950B A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 04/14/2010 | CN1593402B Application of di-amino di-indoly cyclo-nonanoyl imide in the process for preparing anti-tumor medicine |
| 04/14/2010 | CN1465338B Skin activating composition for external used anti-aging preparation |